The Latest Cardiac and Vascular News
Mechanical and aspiration devices to treat peripheral vascular disease, deep vein thrombosis and pulmonary embolism ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has partnered with Innova […]
CHENGDU, China, Feb. 21, 2022 /PRNewswire/ — Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS. “The clearance marks an important milestone for Revotek. We are excited to advance REVOVAS, our […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy […]
First-of-its kind metal-alloy angioplasty scoring sheath effective in treatment of critical arterial stenosis PARK CITY, Utah, Feb. 17, 2022 /PRNewswire/ — Transit Scientific announced continued success with its XO Score Sheath Platform to treat highly-stenosed cardiovascular lesions using low pressure peripheral transluminal angioplasty (PTA). “Calcified stenotic lesions in the iliac and common femoral […]
Rosemont, Ill., Feb. 16, 2022 (GLOBE NEWSWIRE) — The Society for Vascular Surgery and the Enhanced Recovery after Surgery (ERAS®) Society have released a consensus statement intended to help address perioperative challenges faced by vascular surgery patients. The ERAS® pathways have been beneficial for many surgical specialties, and the application […]
IRVINE, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial (“RCT”) comparing the outcomes of patients with intermediate-high risk pulmonary embolism (“PE”) treated with the FlowTriever system versus catheter-directed thrombolysis […]
Access Vascular aims to usher in new model of value-based care delivery for medical devices as it supports hospitals in their mission to transform vascular access outcomes BILLERICA, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI), today announced its partnership with Healthcare Insights (HCIS) to build a value-based […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces that on February 8, 2022, the United States Patent and Trademark Office granted the company a patent for a support catheter used with a small […]
JENA, Germany, Feb. 9, 2022 /PRNewswire/ — Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA is the world’s first and the largest head-to-head RCT investigating the […]
Phase 2a clinical trial evaluating REG-101 for PAD expected to initiate second half of 2022 ROCKVILLE, Md.–(BUSINESS WIRE)–Regio Biosciences (Regio), a Hibiscus BioVentures company, announced today it has entered into an exclusive license agreement with AstraZeneca to further develop REG-101, a novel therapeutic acting on reverse cholesterol transport (RCT). Regio expects to initiate a […]
